Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Caridi

Neurological Surgery Houston, TX Medical Doctor

NPI 1447386560 CMS profile 19841

6400 Fannin St Ste 2150, Houston, TX 77030

Open in the dashboard

General payments

$156,168

259 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$100,000

2 holdings reported · through program year 2025

Research they led as principal investigator

$59,620 paid to institutions, not to them · program years 2023–2025

Through program year 2025, John Caridi of Houston, TX is reported in the CMS Open Payments database as having received $156,168 across 259 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $59,620 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $100,000 across 2 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $26,770 46
2024 General $30,397 47
2023 General $22,379 33
2022 General $28,826 40
2021 General $21,282 58
2020 General $781 15
2019 General $25,733 20
2024 Ownership $50,000 1
2023 Ownership $50,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Caridi
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to John Caridi were reported at $26,770. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year John Caridi Neurological Surgery median Middle half National median
2019 $25,733 $582 $138–$3,006 $163
2020 $781 $294 $76–$2,174 $114
2021 $21,282 $387 $105–$2,432 $132
2022 $28,826 $542 $139–$2,989 $149
2023 $22,379 $534 $145–$2,697 $160
2024 $30,397 $574 $155–$3,046 $164
2025 $26,770 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $77,296 121 payments
  2. Cerapedics, Inc. $39,509 35 payments
  3. NuVasive, Inc. $15,705 1 payment
  4. Zimmer Biomet Holdings, Inc. $9,862 15 payments
  5. SI-BONE, Inc. $4,872 24 payments
  6. Medtronic, Inc. $3,083 25 payments
  7. Baxter Healthcare $2,885 2 payments
  8. Life Spine, Inc. $1,025 3 payments
  9. Alphatec Spine, Inc $405 2 payments
  10. DePuy Synthes Sales Inc. $284 2 payments
  11. Other $1,241 29 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $109,051 29 payments
  2. Travel and Lodging $16,875 62 payments
  3. Royalty or License $15,705 1 payment
  4. Food and Beverage $14,538 167 payments
Products named General payments · program years 2019–2025
  1. EVEREST SPINAL SYSTEM $42,930 54 payments
  2. I-FACTOR PEPTIDE ENHANCED BONE GRAFT $39,509 35 payments
  3. MESA SPINAL SYSTEM $36,000 2 payments
  4. STRYKER NAV3I $21,000 1 payment
  5. COALESCE $15,705 1 payment
  6. CANYON RETRACTOR SYSTEMS $10,125 2 payments
  7. NIAGARA LATERAL ACCESS SYSTEM $7,607 2 payments
  8. IFUSE IMPLANT SYSTEM $3,371 4 payments
  9. Mobi-C $3,300 4 payments
  10. FLOSEAL $2,885 2 payments
  11. Other $24,132 148 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 61 billing codes

Paid by Medicare

$178,248

Medicare's payments for the services billed

Medicare patients

133

Average age 73

Services billed

444

71 women, 62 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Diabetes 41%
Ischemic heart disease 39%
Depression 34%
Chronic kidney disease 23%
Osteoporosis 22%
Heart failure 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

259 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record